Status: Phase 2
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Parkinson Disease; Parkinsonian Disorders Phase 2 ClinicalTrials
Diabetes Mellitus; Diabetes Mellitus, Type 2 Phase 1 ClinicalTrials
Parkinsonian Disorders Phase 2 ClinicalTrials
Parkinson Disease Phase 2 ClinicalTrials
Alzheimer Disease; Dementia; Lewy Body Disease; Parkinson Disease Phase 1/Phase 2 ClinicalTrials
Diabetes Mellitus; Diabetes Mellitus, Type 2 Phase 1 ClinicalTrials
Movement Disorders; Parkinson Disease; Parkinsonian Disorders Phase 2/Phase 3 ClinicalTrials
Nerve Degeneration; Parkinson Disease; Parkinsonian Disorders Phase 2 ClinicalTrials
CONTENTS